Additionally, Co-occurrence of MYD88L265P and CD79B mutations is frequent in ABC DLBCL, suggesting that these two aberrations might be synergistic in driving ABC DLBCL development (27). The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.